(CIDRAP News) A preliminary study linking anthrax vaccinations in pregnant women with an increased risk of birth defects in their babies has prompted the US military to step up efforts to prevent immunization of pregnant women.
(CIDRAP News) BioPort Corp of Lansing, Mich., yesterday received Food and Drug Administration (FDA) approval to begin routine distribution of its anthrax vaccine after more than 3 years of effort to bring its operation up to federal standards.
"FDA is now satisfied that BioPort's renovated facility can produce a vaccine that meets FDA standards for safety and efficacy," the agency said in a news release.
(CIDRAP News) The Centers for Disease Control and Prevention (CDC) says it will take several months to determine if women in the US military who received anthrax vaccine in the first trimester of pregnancy had a greater risk of bearing children with birth defects.
(CIDRAP News) A committee of the Institute of Medicine (IOM) has concluded after 17 months of study that the existing anthrax vaccine is effective and "acceptably safe," but a new vaccine that requires fewer doses and that causes fewer reactions is needed.
(CIDRAP News) Data on more than 300,000 proteins that may have potential as treatments for anthraxthe fruits of a project in which thousands of personal computers were used to analyze billions of moleculeshave been turned over to the US and United Kingdom governments.
(CIDRAP News) It is 13 days since the emergence of a hypothetical smallpox epidemic caused by the release of virus in three US shopping malls. Some 16,000 cases have been reported, 1,000 people have died, and the nation is running out of vaccine. Hospitals are overflowing, and federal and state officials are at odds over how to contain the epidemic.
July 1, 2002 (CIDRAP News) About half of the nation's supply of anthrax vaccinepreviously dedicated almost entirely to military usewill henceforward be set aside for civilian use in the event of another anthrax attack, federal defense and health officials announced Jun 28.
(CIDRAP News) Researchers at Rockefeller University report that they have isolated an enzyme from a bacteriophage that shows promise as a tool to quickly detect and kill Bacillus anthracis, the anthrax bacterium.